The global medical marijuana market was valued at $12bn in 2016 and is projected to grow at a CAGR of 18% in the first half of the forecast period. The market is dominated by the Chronic Pain submarket which held 40% share of that market in 2016.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 120-page report you will receive 87 charts – all unavailable elsewhere.
The 120-page report provides clear detailed insight into the global medical marijuana market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Medical Marijuana Market forecasts from 2017-2027
• Revenue forecast for the medical marijuana market by Application: • Chronic Pain • Arthritis • Migraine • Cancer • Others
Each submarket is further divided by region: North America, Europe, RoW
• This report provides individual revenue forecasts to 2027 for these regional and national medical marijuana markets: • North America: • USA • Canada
• Europe: • Belgium • Croatia • Finland • France • Italy • Rest of Europe
• RoW: • Israel • Australia • Other Countries
• This report discusses the leading companies in the global medical marijuana market: • Cara Therapeutics, Inc. • Cannabis Sativa, Inc. • CannaGrow Holdings, Inc. • Aphios Corporation • United Cannabis Corporation • Growblox Sciences, Inc. • GreenGro Technologies, Inc. • GW Pharmaceutical, PLC. • International Consolidated Companies, Inc. • Lexaria Biosciences Corp.
• This report also listed 84 other companies involved in medical marijuana production, including their reported revenues (when available) and number of employees
• This report provides a patent analysis table for medical marijuana
• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global medical marijuana market
Visiongain’s study is intended for anyone requiring commercial analyses for the global medical marijuana market. You find data, trends and predictions.
Buy our report today Global Medical Marijuana Market 2017-2027: Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Medical Marijuana Market Overview 1.2 Research Methodology 1.2.1 Primary Research 1.2.2 Secondary Research 1.3 Market Evaluation & Forecasting Methodology 1.4 Global Medical Marijuana Market Segmentation 1.5 Overview of Findings 1.6 Why You Should Read This Report 1.7 How This Report Delivers? 1.8 Key Questions Answered by This Analytical Report 1.9 Frequently Asked Questions (FAQ) 1.10 Who is This Report For? 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. Introduction to Medical Marijuana Market
3. Global Medical Marijuana Market Forecast 2017-2027 3.1 Market Breakdown by Application, 2017-2027 3.2 Market Breakdown by Geography, 2017-2027
4. Global Medical Marijuana Market by Application: Market Forecast 2017-2027 4.1 Overview 4.2 Chronic Pain 4.3 Arthritis 4.4 Migraine 4.5 Cancer 4.6 Others
5. Leading National Market, 2017-2027 5.1 Geographical Breakdown of the Global Medical Marijuana Market 5.2 Overview 5.2.1 North America Medical Marijuana Market Forecast, 2017-2027 5.2.1.1 USA Medical Marijuana Market Forecast, 2017-2027 5.2.1.2 Canada Medical Marijuana Market Forecast, 2017-2027 5.2.2 European Medical Marijuana Market Forecast, 2017-2027 5.2.2.1 Belgium Medical Marijuana Market Forecast, 2017-2027 5.2.2.2 Croatia Medical Marijuana Market Forecast, 2017-2027 5.2.2.3 Finland Medical Marijuana Market Forecast, 2017-2027 5.2.2.4 France Medical Marijuana Market Forecast, 2017-2027 5.2.2.5 Italy Medical Marijuana Market Forecast, 2017-2027 5.2.2.6 Rest of Europe Marijuana Market Forecast, 2017-2027 5.2.3 RoW Medical Marijuana Market Forecast, 2017-2027 5.2.3.1 Israel Medical Marijuana Market Forecast, 2017-2027 5.2.3.2 Australia Medical Marijuana Market Forecast, 2017-2027 5.2.3.3 Other Countries Marijuana Market Forecast, 2017-2027
6. Global Medical Marijuana Market, Qualitative Analysis, 2017-2027 6.1 Porter’s Five Forces Analysis of the Medical Marijuana Market 2017-2027 6.1.1 Bargaining Power of Buyers (Low) 6.1.2 Bargaining Power of Suppliers (High) 6.1.3 Threat of New Entrants (Low) 6.1.4 Threat of Substitute Products (High) 6.1.5 Intensity of Competitive Rivalry (High) 6.2 Drivers & Restraints 6.2.1 Increasing Prevalence of Cancer 6.2.2 Increasing Research in Medical Marijuana 6.2.3 Growing Number of Mergers and Acquisitions 6.2.4 Increasing Funding for Cancer Research by Governmental Organisations 6.2.5 Increasing Investment from Government, Public and Private Sector 6.2.6 Increased Focus towards Advanced Treatment Protocols 6.2.7 Increased Awareness to Reduce Healthcare Costs 6.2.8 Opportunities in Emerging Economies 6.3 Patent Analysis
7. Leading Companies in Medical Marijuana Market 7.1 Cara Therapeutics, Inc. 7.1.1 Cara Therapeutics, Inc.: Company Overview 7.1.2 Cara Therapeutics, Inc.: Product Portfolio 7.2 Cannabis Sativa, Inc. 7.2.1 Cannabis Sativa, Inc.: Company Overview 7.2.2 Cannabis Sativa, Inc.: Recent Developments 7.3 CannaGrow Holdings Inc. 7.3.1 CannaGrow Holdings Inc.: Company Overview 7.4 Aphios Corporation 7.4.1 Aphios Corporation: Company Overview 7.4.2 Aphios Corporation: Product Portfolio 7.4.3 Aphios Corporation: Recent Developments 7.5 United Cannabis Corporation 7.5.1 United Cannabis Corporation: Company Overview 7.5.2 United Cannabis Corporation: Recent Developments 7.6 Growblox Sciences, Inc. 7.6.1 Growblox Sciences, Inc.: Company Overview 7.6.2 Growblox Sciences, Inc.: Recent Developments 7.7 GreenGro Technologies, Inc. 7.7.1 GreenGro Technologies, Inc.: Company Overview 7.7.2 GreenGro Technologies, Inc.: Product Portfolio 7.7.3 GreenGro Technologies, Inc.: Recent Developments 7.8 GW Pharmaceuticals, PLC. 7.8.1 GW Pharmaceuticals, PLC.: Company Overview 7.8.2 GW Pharmaceuticals, PLC.: Product Portfolio 7.8.3 GW Pharmaceuticals, PLC.: Recent Developments 7.9 International Consolidated Companies, Inc. 7.9.1 International Consolidated Companies, Inc.: Company Overview 7.10 Lexaria Bioscience Corp. 7.10.1 Lexaria Bioscience Corp.: Company Overview 7.11 Companies involved in Medical Marijuana Production
8. Conclusions 8.1 Current Leading Segments 8.2 Leading Regional Markets 8.3 Emerging Markets 8.4 The Future of the Market?
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form
List of Tables Table 3.1. Global Medical Marijuana Market Forecast ($bn, AGR%, CAGR%) 2017-2027 Table 4.1. Global Medical Marijuana Market Forecast, by Application ($bn, AGR%, CAGR%) 2017-2027 Table 4.2. Global Medical Marijuana Market For Chronic Pain ,Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027 Table 4.4. Global Arthritis for Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 4.5. Global Medical Marijuana Market For Arthritis, Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 4.6. Global Medical Marijuana Market For Migraine Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 4.7. Global Medical Marijuana Market For Migraine Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 4.8. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 4.9. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 4.10. Global Medical Marijuana Market For Other Forecast ($bn, AGR%, CAGR%) 2017-2027 Table 4.11. Global Other Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027 Table 5.2. North America Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027 Table 5.3. USA Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.4. Canada Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.5. European Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027 Table 5.6. Belgium Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.7. Croatia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.8. Finland Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.9. France Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.10. Italy Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.11. Rest of Europe Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.12. Rest of World Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027 Table 5.13. Israel Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.14. Australia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 5.15. Other Countries Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027 Table 6.1. Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012) Table 6.2. Patent Analysis for Medical Marijuana Table 7.1. Cara Therapeutics, Inc.: Company Overview Table 7.2. Cara Therapeutics, Inc.: Product Portfolio Table 7.3. Cannabis Sativa, Inc.: Company Overview Table 7.4. Cannabis Sativa, Inc.: Recent Developments Table 7.5. CannaGrow Holdings Inc.: Company Overview Table 7.6. Aphios Corporation: Company Overview Table 7.7. Aphios Corporation: Product Portfolio Table 7.8. Aphios Corporation.: Recent Developments Table 7.9. United Cannabis Corporation: Company Overview Table 7.10. United Cannabis Corporation.: Recent Developments Table 7.11. Growblox Sciences, Inc.: Company Overview Table 7.12. Growblox Sciences, Inc.: Recent Developments Table 7.13. GreenGro Technologies, Inc.: Company Overview Table 7.14. GreenGro Technologies, Inc.: Product Portfolio Table 7.15. GreenGro Technologies, Inc.: Recent Developments Table 7.16. GW Pharmaceuticals, PLC.: Company Overview Table 7.17. GW Pharmaceuticals, PLC.: Product Portfolio Table 7.18. GW Pharmaceuticals, PLC.: Recent Developments Table 7.19. International Consolidated Companies, Inc.: Company Overview Table 7.20. Lexaria bioscience Corp.: Company Overview Table 7.21. Other Companies Involved in Medical Marijuana Production
List of Figures Figure 3.1. Global Medical Marijuana Market, by Application, ($bn), 2017-2027 Figure 3.2. Global Medical Marijuana Market, by Geography, ($bn), 2017-2027 Figure 4.1. Global Medical Marijuana Market, by Application, Market Share (%), 2016 Figure 4.2. Global Medical Marijuana Market, by Application, Forecast ($bn) 2017-2027 Figure 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027 Figure 4.4. Global Medical Marijuana Market for Arthritis Forecast, by Geography, ($bn) 2017-2027 Figure 4.5. Global Medical Marijuana Market for Migraine Forecast, by Geography, ($bn) 2017-2027 Figure 4.6. Global Medical Marijuana Market for Cancer Forecast, by Geography, ($bn) 2017-2027 Figure 4.7. Global Other Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027 Figure 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn) 2017-2027 Figure 5.2. Global Medical Marijuana Market Forecast, by Geography, Market Share (%), 2016 Figure 5.3. North America Medical Marijuana Market Forecast, by Country ($bn) 2017-2027 Figure 5.4. North America Medical Marijuana Market, by Country, Market Share (%), 2017 Figure 5.5. USA Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.6. Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.7. Europe Medical Marijuana Market Forecast, by Country ($bn) 2017-2027 Figure 5.8. Europe Medical Marijuana Market, by Country, Market Share (%), 2017 Figure 5.9. Belgium Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.10. Croatia Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.11. Finland Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.12. France Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.13. Italy Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.14. Rest of Europe Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.15. Rest of World Medical Marijuana Market Forecast, by Country ($bn) 2017-2027 Figure 5.16. Rest of World Medical Marijuana Market, by Country, Market Share (%), 2016 Figure 5.17. Israel Medical Marijuana Market Forecast ($m) 2017-2027 Figure 5.18. Australia Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 5.19. Other Countries Medical Marijuana Market Forecast ($bn) 2017-2027 Figure 6.1. Porter’s Five Forces Analysis of the Medical Marijuana Market Figure 7.1. Cara Therapeutics, Inc., Revenue, ($m), 2012-2016 Figure 7.2. Cannabis Sativa, Inc., Revenue, ($m), 2014-2016 Figure 7.3. GreenGro Technologies, Inc., Revenue, ($m), 2014-2015 Figure 7.4. GW Pharmaceuticals, PLC. Revenue, ($m), 2012-2016 Figure 7.5. GW Pharmaceuticals, PLC. Geographical Presence Share (%), 2016 Figure 7.6. Lexaria Corp., Revenue, ($m), 2012-2016 Figure 8.1. World Medical marijuana, by Application, ($bn), 2016-2027 Figure 8.2. World Medical marijuana, by Geography, ($bn), 2016-2027
Acacia Diversified Holdings, Inc. Advesa Affinor Growers, Inc. Agritek Holdings, Inc. Aja Cannafacturing, Inc. Alliance Growers Corp. Alphora Research Inc. Alternative Energy Partners, Inc. American Green, Inc. AmeriCann, Inc. Anandia Laboratories Inc. Aphios Corporation Aurora Cannabis, Inc. Avid Growing Systems Inc. Azienda Sanitaria Locale Bang Holdings Corp. Battelle Energy Alliance, LLC Bedrocan Cannabis Corp. Beleave, Inc. Bingo Nation, Inc. Café Serendipity Holdings, Inc. Canada House Wellness Group, Inc. Canadian Cannabis Corp. Cann Group Ltd. Cannabics Pharmaceuticals, Inc. Cannabis Leaf, Inc. Cannabis Sativa, Inc. CannaGrow Holdings, Inc. CannaRoyalty Corp. CannaSys, Inc. CanniMed Therapeutics, Inc. CannLabs, Inc. Canopy Growth Corp. Cara Therapeutics, Inc. Chuma Holdings, Inc. CorGreen Technologies Holding Corp. Cronos Group, Inc. Eden Holdings LLC Embera Neurotherapeutics, Inc Emblem Corp. Emerald Health Therapeutics, Inc. Endocan Corp. Enertopia Corp. Evergreen-Agra, Inc. F Hoffmann La Roche AG Ficaar, Inc. Gala Global, Inc. General Cannabis Corp. Golden Leaf Holdings Ltd. Green & Hill Industries, Inc. Greener Clouds LLC GreenGro Technologies, Inc. Grow Condos, Inc. Grow Solutions Holdings, Inc. Growblox Sciences, Inc. GrowLife, Inc. GW Pharmaceutical, PLC. Hangzhou Alltest Biotech Co., Ltd. Herbal Biotech Pathways Labs Hi Brands International Inc., High Hampton Holdings Corp. Hythiam Inc. iBudtender, Inc. ICC International Cannabis Corp. Incredibowl Industries, LLC Innocorp, Ltd. International Consolidated Companies, Inc. Kaya Holdings, Inc. Kona Gold Solutions, Inc. Kubby Patent and Licenses, LLC Kush Cups Labone, Inc. Lexaria Biosciences Corp. Lotus Ventures, Inc. Maple Leaf Green World, Inc. Marapharm Ventures, Inc. Marijuana Company of America, Inc. MariMed, Inc. Matica Enterprises, Inc. MediJane Holdings, Inc. MedReleaf Corp. Monarch America, Inc. Murty Pharmaceuticals, Inc. Nass Valley Gateway Ltd. Natural Rx Investment Club LLC NEWCO North American Cannabis Holdings, Inc. Northsight Capital, Inc. Notis Global, Inc. Nutritional High International, Inc. Occidental Development Group, Inc. Omeros Corporation Optileaf Inc. OrganiGram Holdings, Inc. PotNetwork Holdings, Inc. Primco Management, Inc. Puration, Inc. Qingdao Aihualong Biotechnology Co., Ltd. Qingdao Chenxuntong Trading Co., Ltd. Qingdao Zhaxi Biological Technology Co., Ltd. Rottapharm S.P.A. Santo Mining Corp. Shanghai Fuzhen Technology Co.,Ltd. Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd. Sixty Six Oilfield Services, Inc. Supreme Pharmaceuticals, Inc. Terra Tech Corp. Tetra Bio-Pharma, Inc. THC Therapeutics, Inc. The Hydroponics Co. Ltd. True Leaf Medicine International Ltd. Tweed Inc. Ultra Sun Corporation United Cannabis Corp. United Cannabis Corporation Verde Science, Inc. Veritas Pharma, Inc. Vessel Life Sciences (VLS) Vodis Pharmaceuticals, Inc. Volo Trade, Inc. WEED, Inc. WeedMD, Inc. Wild Earth Naturals, Inc. Wildflower Marijuana, Inc. Worldwide Marijuana, Inc. Wrapmail Inc. Wuhu Ufabric New Sound-Absorbing Material Co., Ltd. Yingkou Xinyi Textile Co., Ltd
List of Organizations Mentioned in the Report Alaska Department of Health and Social Services Commonwealth Therapeutic Goods Administration Dalian Polytechnic University Drug Policy Alliance (DPA) European Medicines Agency (EMA) Food and Drug Administration (FDA) Health Canada National Agency of the Safety of Medicine and Health Products National Cancer Research Institute National Institutes of Health (NIH) National Research Council of Canada Shanxi University Supreme Court of Canada University Of Saskatchewan World Health Organization
Download sample pages
Complete the form below to download your free sample pages for Global Medical Marijuana Market 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
